{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:42:41Z","timestamp":1762854161352,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.gofs.2019.09.015","type":"journal-article","created":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T10:52:34Z","timestamp":1570272754000},"page":"790-796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["L\u2019ADN f\u0153tal libre circulant\u00a0: un outil d\u2019\u00e9valuation du risque de survenue de complications obst\u00e9tricales\u00a0?"],"prefix":"10.1016","volume":"47","author":[{"given":"C.","family":"Duvillier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Quibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Felsenheld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hupin-Genty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vialard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9076","key":"10.1016\/j.gofs.2019.09.015_bib0205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.gofs.2019.09.015_bib0210","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/pd.4092","article-title":"Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population: Clinical experience of NIPT","volume":"33","author":"Fairbrother","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.gofs.2019.09.015_bib0215","unstructured":"Publication du Conseil superieur de la sant\u00e9 no\u00a08912. Mise en \u0153uvre du screening g\u00e9n\u00e9tique pr\u00e9natal non invasif de la trisomie 21 (Syndrome de Down) dans la pratique des soins de sant\u00e9 en Belgique.pdf [publi\u00e9 le 7 mai 2014]."},{"key":"10.1016\/j.gofs.2019.09.015_bib0220","unstructured":"Recommandations HAS avril 2017. Place des tests ADN libre circulant dans le sang maternel dans le d\u00e9pistage de la trisomie 21\u00a0f\u0153tale [publi\u00e9 en mai 2017]."},{"issue":"2","key":"10.1016\/j.gofs.2019.09.015_bib0225","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajog.2004.12.023","article-title":"High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery","volume":"193","author":"Farina","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2019.09.015_bib0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.02.009","article-title":"Cell-free DNA fetal fraction and preterm birth","volume":"215","author":"Dugoff","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2019.09.015_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2350-10-120","article-title":"Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia [Internet]","volume":"10","author":"Lazar","year":"2009","journal-title":"BMC Med Genet"},{"issue":"11","key":"10.1016\/j.gofs.2019.09.015_bib0240","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1373\/clinchem.2004.036806","article-title":"Variability of serum soluble intercellular adhesion molecule-1\u00a0measurements attributable to a common polymorphism","volume":"50","author":"Register","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.gofs.2019.09.015_bib0245","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.placenta.2013.11.014","article-title":"Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease","volume":"35","author":"Taglauer","year":"2014","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.gofs.2019.09.015_bib0250","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The Global Impact of Pre-eclampsia and Eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"issue":"7\u20138","key":"10.1016\/j.gofs.2019.09.015_bib0255","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.lpm.2016.04.016","article-title":"Physiopathologie de la pr\u00e9-\u00e9clampsie","volume":"45","author":"Lecarpentier","year":"2016","journal-title":"Presse Med"},{"issue":"1","key":"10.1016\/j.gofs.2019.09.015_bib0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gofs.2019.09.015_bib0265","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejogrb.2011.03.004","article-title":"Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption","volume":"157","author":"Ranta","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9575","key":"10.1016\/j.gofs.2019.09.015_bib0270","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.gofs.2019.09.015_bib0275","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1177\/1933719115584445","article-title":"Effects of maternal and fetal characteristics on cell-free fetal DNA fraction in maternal plasma","volume":"22","author":"Zhou","year":"2015","journal-title":"Reprod Sci"},{"issue":"1","key":"10.1016\/j.gofs.2019.09.015_bib0280","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/uog.12331","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11-13\u00a0weeks\u2019 gestation: relation to maternal and fetal characteristics: fetal fraction in maternal plasma cell-free DNA","volume":"41","author":"Ashoor","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2019.09.015_bib0285","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000337373","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11-13\u00a0weeks\u2019 gestation: effect of maternal and fetal factors","volume":"31","author":"Ashoor","year":"2012","journal-title":"Fetal Diagn Ther"},{"issue":"7","key":"10.1016\/j.gofs.2019.09.015_bib0290","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/pd.4126","article-title":"The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies: fetal fraction and non-invasive testing","volume":"33","author":"Canick","year":"2013","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.gofs.2019.09.015_bib0295","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/uog.15851","article-title":"Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result: failed cell-free DNA test","volume":"47","author":"Revello","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"14","key":"10.1016\/j.gofs.2019.09.015_bib0300","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1080\/14767058.2017.1330881","article-title":"Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy","volume":"31","author":"Scott","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.gofs.2019.09.015_bib0305","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/pd.973","article-title":"Total cell-free DNA (\u03b2-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening","volume":"24","author":"Farina","year":"2004","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.gofs.2019.09.015_bib0310","doi-asserted-by":"crossref","DOI":"10.1515\/CCLM.2010.160","article-title":"Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy [Internet]","volume":"48","author":"Galbiati","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"10.1016\/j.gofs.2019.09.015_bib0315","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ajog.2004.01.040","article-title":"Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia","volume":"191","author":"Cotter","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2019.09.015_bib0320","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/pd.1645","article-title":"Free fetal DNA is not increased before 20\u00a0weeks in intrauterine growth restriction or pre-eclampsia","volume":"27","author":"Crowley","year":"2007","journal-title":"Prenat Diagn"},{"issue":"4","key":"10.1016\/j.gofs.2019.09.015_bib0325","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000346806","article-title":"Maternal plasma cell-free fetal and maternal DNA at 11-13\u00a0weeks\u2019 gestation: relation to fetal and maternal characteristics and pregnancy outcomes","volume":"33","author":"Poon","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.gofs.2019.09.015_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/uog.18993","article-title":"Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia: First-trimester markers for pre-eclampsia and cfDNA fetal fraction [Internet]","volume":"52","author":"Rolnik","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2019.09.015_bib0335","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40291-016-0245-9","article-title":"for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis","volume":"21","author":"Contro","year":"2017","journal-title":"Mol Diagn Ther"},{"issue":"7","key":"10.1016\/j.gofs.2019.09.015_bib0340","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gofs.2019.09.015_bib0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.07.063","article-title":"Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction","volume":"200","author":"Alberry","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2019.09.015_bib0350","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000236355","article-title":"Analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction","volume":"26","author":"Al Nakib","year":"2009","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"10.1016\/j.gofs.2019.09.015_bib0355","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1067\/mob.2003.27","article-title":"Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction [Internet]","volume":"188","author":"Sekizawa","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"9144","key":"10.1016\/j.gofs.2019.09.015_bib0360","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/S0140-6736(05)60395-9","article-title":"Maternal plasma fetal DNA as a marker for preterm labour","volume":"352","author":"Leung","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gofs.2019.09.015_bib0365","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/uog.14666","article-title":"Fetal fraction of cell-free DNA in maternal plasma in the prediction of spontaneous preterm delivery","volume":"45","author":"Quezada","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.09.015_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pd.3917","article-title":"High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery: cell free fetal DNA and spontaneous preterm delivery","volume":"32","author":"Jakobsen","year":"2012","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.gofs.2019.09.015_bib0375","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2012.09.006","article-title":"Cell-free fetal DNA and adverse outcome in low risk pregnancies","volume":"166","author":"Stein","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"10.1016\/j.gofs.2019.09.015_bib0380","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/pd.2838","article-title":"Free fetal DNA levels in patients at risk of preterm labour: Free fetal DNA levels in patients at risk of preterm labour","volume":"31","author":"Illanes","year":"2011","journal-title":"Prenat Diagn"},{"issue":"9","key":"10.1016\/j.gofs.2019.09.015_bib0385","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/pd.1513","article-title":"A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome","volume":"26","author":"Bauer","year":"2006","journal-title":"Prenat Diagn"},{"issue":"8","key":"10.1016\/j.gofs.2019.09.015_bib0390","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jgyn.2015.06.010","article-title":"\u00c9pid\u00e9miologie de la pr\u00e9maturit\u00e9: pr\u00e9valence, \u00e9volution, devenir des enfants","volume":"44","author":"Torchin","year":"2015","journal-title":"J Gynecol Obstet Biol Reprod"},{"issue":"12","key":"10.1016\/j.gofs.2019.09.015_bib0395","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.3390\/ijms20122890","article-title":"Exosomes-Associated DNA\u2014New Marker in Pregnancy Complications?","volume":"20","author":"Kone\u010dn\u00e1","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6393","key":"10.1016\/j.gofs.2019.09.015_bib0200","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1126\/science.aar3819","article-title":"Noninvasive blood tests for fetal development predict gestational age and preterm delivery","volume":"360","author":"Ngo","year":"2018","journal-title":"Science"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246871891930306X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246871891930306X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:37:58Z","timestamp":1762853878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246871891930306X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S246871891930306X"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2019.09.015","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L\u2019ADN f\u0153tal libre circulant\u00a0: un outil d\u2019\u00e9valuation du risque de survenue de complications obst\u00e9tricales\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2019.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}